<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03835689</url>
  </required_header>
  <id_info>
    <org_study_id>REB#1023970</org_study_id>
    <nct_id>NCT03835689</nct_id>
  </id_info>
  <brief_title>Strongest FamiliesTM Neurodevelopmental</brief_title>
  <official_title>Parent Training for Challenging Behaviour in Children With Neurodevelopmental Disabilities: Strongest FamiliesTM Neurodevelopmental</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Child-Bright Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IWK Health Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children and adolescents with neurodevelopmental conditions are 3 to 5 times more likely than&#xD;
      their peers to have other mental disorders such as anxiety, depression and disruptive&#xD;
      behaviour. Furthermore, these conditions are less likely to be recognized, diagnosed and&#xD;
      treated than for typically developing children. Parent training is a well-established&#xD;
      approach to help parents change their behaviour and communication with their children with&#xD;
      the goal of improving child behaviours. Parent-focused programs that are designed for&#xD;
      typically developing children have shown mixed results for children with neurodevelopmental&#xD;
      conditions and parents have reported significant challenges in accessing traditional health&#xD;
      services due to barriers to care. There is an urgent need to explore how effective&#xD;
      distance-delivered parenting programs can be implemented in real-world settings and how they&#xD;
      should be adapted to meet the needs of families with children with neurodevelopmental&#xD;
      conditions. The goal of this research project is to develop and test the effectiveness of two&#xD;
      versions (group coaching &amp; self-managed) of an online parenting program for managing&#xD;
      challenging behaviours in children with neurodevelopmental disabilities. The Strongest&#xD;
      Families Neurodevelopmental program is based on the well-established Strongest Families&#xD;
      Parenting program for typically developing children with challenging behaviours, adapted with&#xD;
      substantial involvement from a pan-Canadian Parent Advisory Committee. The program consists&#xD;
      of 11 skill-based sessions with demonstration videos, audio clips, exercises, a resource&#xD;
      webpage and a Parent-to-Parent online group (a closed Facebook group).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 8, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Statistician conducting analysis will be blinded to group assignment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline parenting self-efficacy at 5 month post-randomization</measure>
    <time_frame>Baseline and 5 month post-randomization</time_frame>
    <description>Statistically significant improvement in parent report of self-efficacy from baseline to 5 month follow up for both intervention groups compared to control, as measured by the total score on the Self-Efficacy subscale of the Child Adjustment and Parent Efficacy Scale - Developmental Disability (CAPES-DD) questionnaire. The CAPES-DD assesses emotional and behavioural problems in children with developmental disabilities (age 2 - 16 years) and their parents' self-efficacy to manage specific problematic behaviours. For each of 16 problem child behaviours, respondents are asked to rate their confidence in their ability to successfully manage the behaviour. Ratings range on a scale from 1 ('certain I can't manage it') to 10 ('certain I can manage it'). Total scores range from 16 - 160 with higher scores indicating greater levels of parent self-efficacy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline child's emotion regulation at 5 month post-randomization</measure>
    <time_frame>Baseline and 5 month post-randomization</time_frame>
    <description>Statistically significant improvement in emotion regulation from baseline to 5 months for both intervention groups compared to control, as measured by the total score of the Emotion Regulation Checklist (ERC). The 24-item scale consists of two subscales: Lability/Negativity characterized by inflexibility, mood swings and dysregulated negative affect (e.g., &quot;is prone to angry outbursts/tantrums easily&quot;), and Emotion Regulation representing appropriate affect, empathy and awareness of one's emotions (e.g., &quot;responds positively to neutral or friendly approaches by peers'). Parents are asked to report, on a 4 point Likert-type scale ranging from Never to Almost Always, how much each statement applies to their child. An overall emotional regulation score is calculated by reverse scoring the Emotion Regulation items and summing all questionnaire items; a higher score indicating more dysregulation. We will use total scores which range from 23 - 92 (item 12 is not used in the calculation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline parenting self-efficacy at 10 month post-randomization</measure>
    <time_frame>Baseline and 10 month post-randomization</time_frame>
    <description>Statistically significant improvement in parent report of self-efficacy from baseline to 10 month follow up for both intervention groups compared to control, as measured by the total score of the Self-Efficacy subscale of the Child Adjustment and Parent Efficacy Scale - Developmental Disability (CAPES-DD) questionnaire. The CAPES-DD assesses emotional and behavioural problems in children with developmental disabilities (age 2 - 16 years) and their parents' self-efficacy to manage specific problematic behaviours. For each of 16 problem child behaviours, respondents are asked to rate their confidence in their ability to successfully manage the behaviour. Ratings range on a scale from 1 ('certain I can't manage it') to 10 ('certain I can manage it'). Total scores range from 16 - 160 with higher scores indicating greater levels of parent self-efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline child's emotion regulation at 10 month post-randomization</measure>
    <time_frame>Baseline and 10 month post-randomization</time_frame>
    <description>Statistically significant improvement in emotion regulation from baseline to 10 months for both intervention groups compared to control, as measured by the total score of the Emotion Regulation Checklist (ERC).The 24-item scale consists of two subscales: Lability/Negativity characterized by inflexibility, mood swings and dysregulated negative affect (e.g., &quot;is prone to angry outbursts/tantrums easily&quot;), and Emotion Regulation representing appropriate affect, empathy and awareness of one's emotions (e.g., &quot;responds positively to neutral or friendly approaches by peers'). Parents are asked to report, on a 4 point Likert-type scale ranging from Never to Almost Always, how much each statement applies to their child. An overall emotional regulation score is calculated by reverse scoring the Emotion Regulation items and summing all questionnaire items; a higher score indicating more dysregulation. We will use total scores which range from 23 - 92 (item 12 is not used in the calculation).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduced children's externalizing behaviours</measure>
    <time_frame>Baseline, 5 and 10 month post-randomization</time_frame>
    <description>Statistically significant reduction in child's behavior problems between baseline and 5 months and baseline and 10 months for both interventions groups compared to control, as measured by the Difficulties score of the Strengths and Difficulties Questionnaire (SDQ). The SDQ measures children's emotional problems, conduct disorder, hyperactivity, peer problems and prosocial behavior. The Total Difficulties scores is calculated by summing all scores except items on the prosocial scale. Scores range from 0 - 40 with higher scores indicating more problematic behavior.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved parental well-being</measure>
    <time_frame>Baseline, 5 and 10 month post-randomization</time_frame>
    <description>Statistically significant reduction of parent report of depression, anxiety and stress from baseline to 5 months and baseline to 10 months for both interventions groups compared to control, as measured by total score of the Depression, Anxiety, Stress Scale - 21 (DASS-21). The DASS-21 measures severity of symptoms related to depression, anxiety and stress. Respondents rate how much each symptom applied to them in the past week using a scale from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time). Total scores are calculated by summing responses and multiplying by 2 to allow comparison to severity scores established with the long form of the DASS which has 42 items (e.g. normal to extremely severe). Scores range from 0 - 126, with higher scores indicating more distress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental Cost-Effectiveness Ratio (ICER) - Child</measure>
    <time_frame>Baseline, 5 and 10 month post-randomization</time_frame>
    <description>ICER are calculated by dividing the difference in cost by the difference in effectiveness when comparing two interventions and represent the additional cost or savings associated with gaining or losing an additional unit of effectiveness. To assess the value for money of an intervention relative to another, decision-makers can compare ICER values to the amount their jurisdiction would be willing to pay to gain or willing to accept to forgo a unit of the effectiveness outcome that was included in the ICER. Cost will be measured in Canadian dollars and effectiveness will be measured using quality adjusted life years (QALY). Cost and effectiveness will reflect those of the child.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">454</enrollment>
  <condition>Neurodevelopmental Disorders</condition>
  <condition>Behavior Disorders</condition>
  <arm_group>
    <arm_group_label>Strongest Families Program Self-Managed (no coaching)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>They will receive Strongest Families intervention immediately as well as the usual care services available for the 10 month study period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Strongest Families Program with Group Telephone Coaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>They will receive Strongest Families intervention immediately as well as the usual care services available for the 10 month study period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information Resource Website</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>They will not receive Strongest Families Intervention during the 10 month study phase, but will receive the usual care services and access to an Information Resource Website.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Strongest Families Intervention (formerly Family Help)</intervention_name>
    <description>Distance HEALTH education intervention focused on skill learning for parents</description>
    <arm_group_label>Strongest Families Program Self-Managed (no coaching)</arm_group_label>
    <arm_group_label>Strongest Families Program with Group Telephone Coaching</arm_group_label>
    <other_name>Formerly the Family Help Program</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        SCREENING: Parents/caregivers must meet all of the following criteria to be eligible to&#xD;
        proceed to Consent:&#xD;
&#xD;
          1. Have a child between 3-14 years of age with a diagnosis of a neurodevelopmental&#xD;
             disorder (i.e. Autism Spectrum Disorder, Cerebral Palsy, Epilepsy, Global&#xD;
             Developmental Delay, Down Syndrome, Fetal Alcohol Spectrum Disorder (FASD), severe&#xD;
             learning disability or any other diagnosis that influences how their child gets&#xD;
             around, communicates their ideas, processes what they hear, or remembers things as&#xD;
             reported by parents/caregivers).&#xD;
&#xD;
          2. The child has been experiencing behavioural problems that interfere with the&#xD;
             activities of daily living (as defined by the caregiver) for at least 6 months prior&#xD;
             to study screening.&#xD;
&#xD;
          3. Have been the primary caregiver for a minimum of 6 months prior to entry into the&#xD;
             study.&#xD;
&#xD;
          4. Have a reasonable expectation of being be the primary caregiver for at least 10 months&#xD;
             after study enrolment.&#xD;
&#xD;
          5. Read, write, and understand English.&#xD;
&#xD;
          6. Have access to a telephone.&#xD;
&#xD;
          7. Have regular access to a tablet, smartphone or computer connected to high speed&#xD;
             Internet.&#xD;
&#xD;
          8. Live in Canada.&#xD;
&#xD;
          9. Commit to the requirements of taking part in the study (e.g. available to attend&#xD;
             weekly coaching calls, having a Facebook account to access Parent-to-Parent support&#xD;
             group)&#xD;
&#xD;
        Any of the following criteria will exclude individuals from proceeding to Consent:&#xD;
&#xD;
          1. Child is NOT able to understand everyday language and instructions or communicate&#xD;
             needs as reported by parent/caregiver.&#xD;
&#xD;
          2. Parent or child has ongoing struggles with symptoms of psychosis, schizophrenia,&#xD;
             bipolar disorder or major depression (i.e. the symptoms are not well managed).&#xD;
&#xD;
          3. Child is at imminent risk of serious harm to self or others (i.e. requiring&#xD;
             hospitalization or medical attention).&#xD;
&#xD;
          4. Child regularly engages in moderate to severe self-injurious behaviours, as reported&#xD;
             by the parent.&#xD;
&#xD;
          5. Child has attempted suicide in the past 6 months.&#xD;
&#xD;
          6. Parent has previously taken part in a Strongest Families Parenting Program.&#xD;
&#xD;
          7. Parent has taken part in Triple P, COPE, Incredible Years or another parent training&#xD;
             program within 6 months prior to starting the study.&#xD;
&#xD;
        BASELINE ASSESSMENT:&#xD;
&#xD;
          1. Meet minimum score of 16 (for ages 2 - 4 years) or 17 (for ages 4-17) on the Total&#xD;
             Difficulties Score of the Strengths and Difficulties Questionnaire.&#xD;
&#xD;
          2. Meet a minimum level of child's cognitive functioning as determined by the question*&#xD;
             below. Parents must endorse 1, 2 or 3 on the following question:&#xD;
&#xD;
        Compared with children of the same age, does your child have difficulty learning things?&#xD;
        Would you say your child has: no difficulty, some difficulty, a lot of difficulty or cannot&#xD;
        do at all? No difficulty........................ 1 Some difficulty....................2 A&#xD;
        lot of difficulty..................3 Cannot do at .....................4&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick J McGrath, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IWK Health Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lucyna Lach, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2022</verification_date>
  <study_first_submitted>February 4, 2019</study_first_submitted>
  <study_first_submitted_qc>February 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2019</study_first_posted>
  <last_update_submitted>March 29, 2022</last_update_submitted>
  <last_update_submitted_qc>March 29, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IWK Health Centre</investigator_affiliation>
    <investigator_full_name>Patrick J. McGrath</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Behavioural intervention</keyword>
  <keyword>E-health intervention</keyword>
  <keyword>Parenting intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Neurodevelopmental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participants will be asked to indicate during Informed Consent whether their de-identified data may be shared with other researchers, provided the study is approved by an ethics board and researchers agree to use the data only for the purposes described in the approved research study. De-identified data from all outcome measures will be made available to approved researchers upon request, provided individual participants have provided consent.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03835689
org study id: REB#1023970
nct id: NCT03835689
lead sponsor: 
collaborator: 
collaborator: 
collaborator: 
collaborator: 
has dmc: No
is fda regulated drug: No
is fda regulated device: No
Children and adolescents with neurodevelopmental conditions are 3 to 5 times more likely than
      their peers to have other mental disorders such as anxiety, depression and disruptive
      behaviour. Furthermore, these conditions are less likely to be recognized, diagnosed and
      treated than for typically developing children. Parent training is a well-established
      approach to help parents change their behaviour and communication with their children with
      the goal of improving child behaviours. Parent-focused programs that are designed for
      typically developing children have shown mixed results for children with neurodevelopmental
      conditions and parents have reported significant challenges in accessing traditional health
      services due to barriers to care. There is an urgent need to explore how effective
      distance-delivered parenting programs can be implemented in real-world settings and how they
      should be adapted to meet the needs of families with children with neurodevelopmental
      conditions. The goal of this research project is to develop and test the effectiveness of two
      versions (group coaching & self-managed) of an online parenting program for managing
      challenging behaviours in children with neurodevelopmental disabilities. The Strongest
      Families Neurodevelopmental program is based on the well-established Strongest Families
      Parenting program for typically developing children with challenging behaviours, adapted with
      substantial involvement from a pan-Canadian Parent Advisory Committee. The program consists
      of 11 skill-based sessions with demonstration videos, audio clips, exercises, a resource
      webpage and a Parent-to-Parent online group (a closed Facebook group).
allocation: Randomized
intervention model: Parallel Assignment
primary purpose: Treatment
masking: Single (Outcomes Assessor)
masking description: Statistician conducting analysis will be blinded to group assignment
measure: Change from baseline parenting self-efficacy at 5 month post-randomization
time frame: Baseline and 5 month post-randomization
description: Statistically significant improvement in parent report of self-efficacy from baseline to 5 month follow up for both intervention groups compared to control, as measured by the total score on the Self-Efficacy subscale of the Child Adjustment and Parent Efficacy Scale - Developmental Disability (CAPES-DD) questionnaire. The CAPES-DD assesses emotional and behavioural problems in children with developmental disabilities (age 2 - 16 years) and their parents' self-efficacy to manage specific problematic behaviours. For each of 16 problem child behaviours, respondents are asked to rate their confidence in their ability to successfully manage the behaviour. Ratings range on a scale from 1 ('certain I can't manage it') to 10 ('certain I can manage it'). Total scores range from 16 - 160 with higher scores indicating greater levels of parent self-efficacy.
measure: Change from baseline child's emotion regulation at 5 month post-randomization
time frame: Baseline and 5 month post-randomization
description: Statistically significant improvement in emotion regulation from baseline to 5 months for both intervention groups compared to control, as measured by the total score of the Emotion Regulation Checklist (ERC). The 24-item scale consists of two subscales: Lability/Negativity characterized by inflexibility, mood swings and dysregulated negative affect (e.g., "is prone to angry outbursts/tantrums easily"), and Emotion Regulation representing appropriate affect, empathy and awareness of one's emotions (e.g., "responds positively to neutral or friendly approaches by peers'). Parents are asked to report, on a 4 point Likert-type scale ranging from Never to Almost Always, how much each statement applies to their child. An overall emotional regulation score is calculated by reverse scoring the Emotion Regulation items and summing all questionnaire items; a higher score indicating more dysregulation. We will use total scores which range from 23 - 92 (item 12 is not used in the calculation).
measure: Change from baseline parenting self-efficacy at 10 month post-randomization
time frame: Baseline and 10 month post-randomization
description: Statistically significant improvement in parent report of self-efficacy from baseline to 10 month follow up for both intervention groups compared to control, as measured by the total score of the Self-Efficacy subscale of the Child Adjustment and Parent Efficacy Scale - Developmental Disability (CAPES-DD) questionnaire. The CAPES-DD assesses emotional and behavioural problems in children with developmental disabilities (age 2 - 16 years) and their parents' self-efficacy to manage specific problematic behaviours. For each of 16 problem child behaviours, respondents are asked to rate their confidence in their ability to successfully manage the behaviour. Ratings range on a scale from 1 ('certain I can't manage it') to 10 ('certain I can manage it'). Total scores range from 16 - 160 with higher scores indicating greater levels of parent self-efficacy.
measure: Change from baseline child's emotion regulation at 10 month post-randomization
time frame: Baseline and 10 month post-randomization
description: Statistically significant improvement in emotion regulation from baseline to 10 months for both intervention groups compared to control, as measured by the total score of the Emotion Regulation Checklist (ERC).The 24-item scale consists of two subscales: Lability/Negativity characterized by inflexibility, mood swings and dysregulated negative affect (e.g., "is prone to angry outbursts/tantrums easily"), and Emotion Regulation representing appropriate affect, empathy and awareness of one's emotions (e.g., "responds positively to neutral or friendly approaches by peers'). Parents are asked to report, on a 4 point Likert-type scale ranging from Never to Almost Always, how much each statement applies to their child. An overall emotional regulation score is calculated by reverse scoring the Emotion Regulation items and summing all questionnaire items; a higher score indicating more dysregulation. We will use total scores which range from 23 - 92 (item 12 is not used in the calculation).
measure: Reduced children's externalizing behaviours
time frame: Baseline, 5 and 10 month post-randomization
description: Statistically significant reduction in child's behavior problems between baseline and 5 months and baseline and 10 months for both interventions groups compared to control, as measured by the Difficulties score of the Strengths and Difficulties Questionnaire (SDQ). The SDQ measures children's emotional problems, conduct disorder, hyperactivity, peer problems and prosocial behavior. The Total Difficulties scores is calculated by summing all scores except items on the prosocial scale. Scores range from 0 - 40 with higher scores indicating more problematic behavior.
measure: Improved parental well-being
time frame: Baseline, 5 and 10 month post-randomization
description: Statistically significant reduction of parent report of depression, anxiety and stress from baseline to 5 months and baseline to 10 months for both interventions groups compared to control, as measured by total score of the Depression, Anxiety, Stress Scale - 21 (DASS-21). The DASS-21 measures severity of symptoms related to depression, anxiety and stress. Respondents rate how much each symptom applied to them in the past week using a scale from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time). Total scores are calculated by summing responses and multiplying by 2 to allow comparison to severity scores established with the long form of the DASS which has 42 items (e.g. normal to extremely severe). Scores range from 0 - 126, with higher scores indicating more distress.
measure: Incremental Cost-Effectiveness Ratio (ICER) - Child
time frame: Baseline, 5 and 10 month post-randomization
description: ICER are calculated by dividing the difference in cost by the difference in effectiveness when comparing two interventions and represent the additional cost or savings associated with gaining or losing an additional unit of effectiveness. To assess the value for money of an intervention relative to another, decision-makers can compare ICER values to the amount their jurisdiction would be willing to pay to gain or willing to accept to forgo a unit of the effectiveness outcome that was included in the ICER. Cost will be measured in Canadian dollars and effectiveness will be measured using quality adjusted life years (QALY). Cost and effectiveness will reflect those of the child.
arm group label: Strongest Families Program Self-Managed (no coaching)
arm group type: Experimental
description: They will receive Strongest Families intervention immediately as well as the usual care services available for the 10 month study period.
arm group label: Strongest Families Program with Group Telephone Coaching
arm group type: Experimental
description: They will receive Strongest Families intervention immediately as well as the usual care services available for the 10 month study period.
arm group label: Information Resource Website
arm group type: No Intervention
description: They will not receive Strongest Families Intervention during the 10 month study phase, but will receive the usual care services and access to an Information Resource Website.
intervention type: Behavioral
intervention name: Strongest Families Intervention (formerly Family Help)
description: Distance HEALTH education intervention focused on skill learning for parents
arm group label: Strongest Families Program Self-Managed (no coaching)
arm group label: Strongest Families Program with Group Telephone Coaching
other name: Formerly the Family Help Program
criteria: 
gender: All
minimum age: 3 Years
maximum age: 14 Years
healthy volunteers: Accepts Healthy Volunteers
last name: Patrick J McGrath, PhD
role: Principal Investigator
affiliation: IWK Health Centre
last name: Lucyna Lach, PhD
role: Principal Investigator
affiliation: McGill University
facility: 
country: Canada
responsible party type: Principal Investigator
investigator affiliation: IWK Health Centre
investigator full name: Patrick J. McGrath
investigator title: Principal investigator
mesh term: Mental Disorders
mesh term: Neurodevelopmental Disorders
sharing ipd: Yes
ipd description: Participants will be asked to indicate during Informed Consent whether their de-identified data may be shared with other researchers, provided the study is approved by an ethics board and researchers agree to use the data only for the purposes described in the approved research study. De-identified data from all outcome measures will be made available to approved researchers upon request, provided individual participants have provided consent.
ipd info type: Study Protocol
ipd info type: Statistical Analysis Plan (SAP)
ipd info type: Informed Consent Form (ICF)